Document is current

Article History

Received: 14 September 2022

Accepted: 10 October 2022

First Online: 26 October 2022

Declarations

:

: MLB has received consultancy, lecture fees and honoraria from Abiogen, Alexion, Amgen, Bruno Farmaceutici, Kyowa Kirin, Servier, and SPA. EC is consultant for DiaSorin, Fujirebio, IDS, Menarini, Nittobo and bioMérieux. NCH has received consultancy, lecture fees and honoraria from Alliance for Better Bone Health, AMGEN, MSD, Eli Lilly, Servier, UCB, Shire, Consilient Healthcare, Kyowa Kirin and Internis Pharma. SM reports grants from Sanofi, MSD, GSK, Pfizer, Takeda, Mylan through institution as organizer of meetings/congresses and as principal investigator of epidemiological studies, for taking part to advisory boards and expert meetings. CC has received consultancy, lecture fees and honoraria from AMGEN, GSK, Alliance for Better Bone Health, MSD, Eli Lilly, Pfizer, Novartis, Servier, Medtronic and Roche. OBr reports consulting or lecture fees for AMGEN, Aptissen, Biophytis, IBSA, MEDA, Mylan, Novartis, Sanofi, TRB Chemedica, UCB, Viatris outside this manuscript subject. BC has received fees for lectures or scientific advisory boards from Alexion, AMGEN Aptissen, BMS, Expanscience, Ferring, Lilly, Kyowa-Kirin, MSD, Novartis, Roche diagnostics, Sublimed, Theramex, UCB, Viatris. ACJ has received fees for performing educational activities from Abbott Nutrition, Nutricia/Danone, Nestlé Medical Nutrition and Fresenius Kabi and consulting fees from Rejuvenate Biomed, Reneo Pharmaceuticals and Akros Pharma. AC has received fees for lectures or scientific advisory boards from Bristol Myers Squibb and Nestle. BD-H has received grants through her institution for research from DSM and Pfizer, for Data Safety and Monitoring board membership from AgNovos, and a lecture fee from Grupo Italfarmaco. RAF reports stock options from Inside Tracker and Axcella Health and consultancy from Nestle’, Biophytis, Pfizer, Rejuvenate Biomed, and Chugai. TT has received consultancy/speaker’s fees from AMGEN, Arrow, Biogen, Chugai, Expanscience, Grunenthal, Jansen, LCA, Lilly, MSD, Nordic, Novartis, Pfizer, Sanofi, Thuasne, Theramex, TEVA and UCB and financial support or fees for research activities from: Bone Therapeutics, Chugai, UCB. NV reports personal fees from IBSA, Mylan, Viatris, Fidia, MSD outside of the submitted work. JYR reports consulting fees or advisory board participation for IBSA-Genevrier, Mylan, Radius Health, Pierre Fabre, Faes Pharma, Rejuvenate Biomed, Samumed, TEVA, Theramex, Pfizer, Mithra Pharmaceuticals, lecturing fees for IBSA-Genevrier, Mylan, Cniel, Dairy Research Council (DRC), Nutricia, Danone, Agnovos and grant support from IBSA-Genevrier, Mylan, Cniel, Radius Health and TRB. RR has received fees for lectures or scientific advisory boards from Abiogen, Danone, Echolight, European Milk Forum, Nestlé, ObsEva, Pfizer Consumer Health and Theramex. TC, KDC, NAD, OB, MR, NF, JAK, PH, JMK, OL, AL, MPY, RPR, JAT, MW have no conflict of interest or disclosures with regard to this manuscript.

: Approval from the institutional review board was not required for this study.

: This article does not contain any studies with human participants or animals not previously published. All procedures performed in the previously published by the author were in accordance with ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments.

: For this review, formal consent was not required.